The Future of Migraine

The Future of Migraine

Lasmiditan is an innovative therapy in development by CoLucid, the first from a novel drug class called “ditans.”

Unlike triptans, lasmiditan penetrates the centeral nervous system (CNS) and selectively targets 5‑HT1F receptors expressed in the trigeminal nerve pathway to offer effective treatment for migraine through a non-vasoconstrictive mechanism of action.

Learn More

Migraine is a Serious Neurological Disease

Migraine is a Serious Neurological Disease

Migraine is more than headache pain. Migraine has multiple symptoms, which may include extreme sensitivity to light and sound, as well as nausea. A migraine attack can last from several hours to several days and severely impair daily function. Migraine can continue over a lifetime.

Learn More